For example, increased activity of GSK3β in AD has been reported in many studies, which might contribute to ALP inhibition by promoting TFEB phosphorylation and subsequent cytoplasmic retention (Ly et al., 2013; Li et al., 2016). The gene discussed is GSK3B; the disease is Alzheimer disease.